🇺🇸 FDA
Patent

US 8268323

Conformationally stabilized HIV envelope immunogens

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 8268323 (Conformationally stabilized HIV envelope immunogens) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K39/12